NCT05950594 2026-03-16
IVIM & OLINK in Sarcoma
University Health Network, Toronto
Phase 2 Recruiting
Clinical Trials
17 trialsNCT06660810 2026-01-15
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
University of Iowa
Phase 2 Active not recruiting
NCT06835049 2025-12-30
TNT-HYPE
Swiss Cancer Institute
Phase 2 Recruiting
NCT02789384 2025-12-02
NEOSarcomics
Institut Bergonié
Phase NA Recruiting
NCT03217266 2025-09-23
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT06670976 2025-08-26
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT03116529 2024-11-04
NEXIS
University of Maryland, Baltimore
Phase 1/2 Terminated
NCT01819831 2023-08-23
A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall
Loma Linda University
Phase NA Completed
NCT05602415 2022-11-02
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Ruijin Hospital
Phase 2 Unknown
NCT02496520 2020-02-21
DEND/TIA
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2 Completed
NCT00589121 2019-06-12
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
Radiation Therapy Oncology Group
Phase 2 Completed
NCT02579980 2019-03-26
Quantitative Imaging Biomarkers for Sarcoma
Columbia University
Phase NA Completed
NCT00356031 2017-05-19
Bevacizumab and Radiation Therapy for Sarcomas
Massachusetts General Hospital
Phase 2 Completed
NCT00901836 2017-02-10
SA03
University of Florida
Phase NA Terminated
NCT00017160 2013-06-27
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Radiation Therapy Oncology Group
Phase 2 Withdrawn
NCT00003667 2013-06-25
Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00003776 2013-06-21
Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed